Tenet Healthcare Corporation (THC) – What Are Investment Firms Saying About This Stock?

Shares of Tenet Healthcare Corporation (NYSE:THC) have earned a consensus recommendation of “Moderate Buy” from the twenty-one brokerages that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and eighteen have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $277.25.

THC has been the topic of a number of recent analyst reports. Morgan Stanley increased their price target on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a report on Monday, July 27th. Royal Bank Of Canada boosted their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a research note on Monday, July 27th. Zacks Research lowered shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 29th. Truist Financial upped their target price on shares of Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a report on Tuesday, July 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research note on Friday, October 2nd.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $268.76 on Tuesday. The stock has a market cap of $21.64 billion, a PE ratio of 10.36, a price-to-earnings-growth ratio of 1.01 and a beta of 1.20. Tenet Healthcare has a fifty-two week low of $157.58 and a fifty-two week high of $283.05. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The stock has a fifty day moving average of $263.45 and a 200-day moving average of $217.14.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%. The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. During the same period in the previous year, the company posted $4.02 EPS. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities research analysts anticipate that Tenet Healthcare will post 21.04 earnings per share for the current year.

Insider Activity

In related news, EVP Paola M. Arbour sold 10,878 shares of the stock in a transaction on Monday, July 27th. The stock was sold at an average price of $243.90, for a total value of $2,653,144.20. Following the sale, the executive vice president owned 18,413 shares in the company, valued at approximately $4,490,930.70. This trade represents a 37.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Richard J. Mark sold 10,000 shares of Tenet Healthcare stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total value of $2,634,200.00. Following the sale, the director directly owned 25,121 shares of the company’s stock, valued at $6,617,373.82. This represents a 28.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 131,199 shares of company stock worth $35,065,587. Company insiders own 0.97% of the company’s stock.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors have recently added to or reduced their stakes in the business. PeakShares LLC raised its position in Tenet Healthcare by 3.3% in the 1st quarter. PeakShares LLC now owns 1,693 shares of the company’s stock worth $319,000 after purchasing an additional 54 shares during the period. Sanctuary Advisors LLC grew its stake in shares of Tenet Healthcare by 0.5% during the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock valued at $2,246,000 after buying an additional 57 shares during the last quarter. Applied Finance Capital Management LLC grew its stake in shares of Tenet Healthcare by 3.8% during the first quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock valued at $310,000 after buying an additional 60 shares during the last quarter. Tidal Investments LLC increased its holdings in shares of Tenet Healthcare by 0.6% in the second quarter. Tidal Investments LLC now owns 13,296 shares of the company’s stock worth $2,487,000 after buying an additional 79 shares during the period. Finally, Wedmont Private Capital increased its holdings in shares of Tenet Healthcare by 5.0% in the third quarter. Wedmont Private Capital now owns 2,139 shares of the company’s stock worth $557,000 after buying an additional 102 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation is a Dallas-based healthcare services company that operates hospitals, outpatient facilities and other healthcare businesses across the United States. Its operations include acute care hospitals, specialty hospitals, ambulatory surgery centers and related outpatient services.

Through its United Surgical Partners International subsidiary, Tenet is one of the major operators and developers of ambulatory surgery centers in the United States. These facilities provide same-day surgical procedures and other outpatient care across a range of medical specialties.